FDA Extends Shelf-Life for Naloxone Nasal Spray
The FDA has extended the shelf-life of 4 mg naloxone hydrochloride nasal spray (Narcan) for nonprescription over-the-counter use from 3 years to 4 years.
Source: hcplive.com
Page 2 - Prevention Framework News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Prevention Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Prevention Framework Today - Breaking & Trending Today
FDA Greenlights Genetic Test to Gauge Opioid Addiction Risk
The test will help healthcare providers to assess an individual's risk of developing opioid use disorder, offering a new approach to pain management.
Source: medscape.com
FDA approves Buprenorphine treatment option for opioid addiction
EYEWITNESS NEWS (WBRE/WYOU) — The U.S. Food and Drug Administration (FDA) approved a Buprenorphine treatment option for opioid addiction. According to the FDA, Brixadi is an extended-release injection for use under the skin (subcutaneously) to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two forms, a weekly injection for patients who […]
Source: yahoo.com
Nigeria: ECOWAS Commission pledges sustained collaboration with political stakeholders - Liberia news The New Dawn Liberia, premier resource for latest news
The ECOWAS Commission has pledged sustained collaboration with Nigerian political actors and stakeholders towards holding violent-free and credible general elections in February and March 2023.
Source: thenewdawnliberia.com
Biden-Harris Administration Announces $74.4 Million in Funding Opportunities to Improve Behavioral Health
Press Release for $74.4 million mental health dollars.
Source: hhs.gov